Composite Hydrophilic Membrane Electrode, Membrane Capacitor Cell, Preparation Method and use Thereof
US-2024312707-A1 · Sep 19, 2024 · US
US9259685B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9259685-B2 |
| Application number | US-201514603524-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 23, 2015 |
| Priority date | Dec 16, 2009 |
| Publication date | Feb 16, 2016 |
| Grant date | Feb 16, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A curable composition comprising: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 12 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and a cationic group; (iii) 10 to 70 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; and (v) non-curable salt; wherein the molar ratio of (i):(ii) is >0.10. The compositions are useful for preparing ion exchange membranes.
Opening claim text (preview).
The invention claimed is: 1. A membrane obtained from a process comprising the following steps: applying a curable composition to a support; and curing the composition to form a membrane; wherein the curable composition comprises: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 12 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and a cationic group; (iii) 10 to 70 wt % solvent; (iv) 0 to 10 wt % of free radical initiator; and (v) non-curable salt comprising a cation and an anion, wherein the anion is not sulfate; wherein the molar ratio of (i):(ii) is greater than and less than 5 0.10. 2. The membrane according to claim 1 wherein the total wt % of components (i) and (ii) relative to the total weight of the composition is 30 to 88 wt %. 3. The membrane according to claim 1 comprising 2 to 50 wt % of non-curable salt as component (v). 4. The membrane according to claim 1 wherein the molar ratio of (i):(ii) is at least 0.15 and which comprises 20 to 65 wt % of component (ii). 5. The membrane according to claim 1 wherein the solvent comprises water and a water-miscible organic solvent. 6. The membrane according to claim 1 which comprises 0.005 to 10 wt % photoinitiator as component (iv). 7. The membrane according to claim 1 which is free from ethylenically unsaturated compounds other than components (i) and (ii). 8. The membrane according to claim 1 wherein the ethylenically unsaturated group is an acrylamide or a methacrylamide group. 9. The membrane according to claim 1 wherein the composition comprises: (i) 5 to 35 wt % crosslinker comprising at least two acrylamide groups; (ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and a cationic group; and (iii) 16 to 45 wt % solvent; (iv) 0.01 to 2 wt % of photoinitiator; and (v) 3 to 40 wt % of non-curable salt comprising a cation and an anion, wherein the anion is not sulfate; wherein the molar ratio of (i):(ii) is at least 0.15. 10. The membrane according to claim 1 wherein the molar ratio of (i):(ii) is at least 0.15 and less than 1.5. 11. The membrane according to claim 1 wherein the composition is cured by irradiation with an electron beam or UV light for a period of less than 30 seconds. 12. The membrane according to claim 1 wherein the curable composition is applied continuously to a moving support using a manufacturing unit comprising a curable composition application station, an irradiation source for curing the composition, and a membrane collecting station and wherein the support moves from the curable composition application station to the irradiation source and to the membrane collecting station. 13. The membrane according to claim 9 wherein the molar ratio of (i):(ii) is less than 1.5.
Dialytic cells or batteries; Reverse electrodialysis cells or batteries · CPC title
electrodeionisation · CPC title
Capacitive deionisation · CPC title
by chemical reactions (in-situ polymerisation, polycondensation, cross-linking or reaction for manufacturing composite membranes B01D69/125) · CPC title
by chemical reactions, e.g. in situ polymerisation or in situ crosslinking · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.